We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), expected in Q1...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.025 | -11.754587156 | 8.72 | 8.8 | 7.3 | 1249279 | 8.22363988 | CS |
4 | 1.695 | 28.25 | 6 | 10.38 | 5.9 | 2775000 | 8.60625038 | CS |
12 | 1.835 | 31.3139931741 | 5.86 | 14.6 | 3.785 | 3916278 | 7.8118942 | CS |
26 | 1.495 | 24.1129032258 | 6.2 | 14.6 | 3.785 | 1907532 | 7.70037206 | CS |
52 | 6.395 | 491.923076923 | 1.3 | 14.6 | 1.16 | 2457426 | 7.1229137 | CS |
156 | 1.245 | 19.3023255814 | 6.45 | 14.6 | 0.66 | 880877 | 6.71256876 | CS |
260 | -0.305 | -3.8125 | 8 | 14.78 | 0.66 | 773420 | 6.74909855 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions